INS and metabolic dysfunction-associated steatotic liver disease: Similarly, there were significantly greater decreases in liver function parameters (AST, ALT, and GGT) and improvements of insulin sensitivity (HOMA-IR) among individuals with NAFLD compared to individuals without NAFLD at baseline.